Clinical Trial Update: AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 trial AMO-01 for Phelan-McDermid Syndrome with epilepsy has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Phelan-mcdermid Syndrome

Drugs mentioned

• AMO-01

Snippet

Sponsor: Alexander Kolevzon | Conditions: Phelan-McDermid Syndrome, Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2021-06-22